Phenacetin can be metabolized to reactive metabolites by a variety of mechanisms. (1) Phenacetin can be N-hydroxylated, and the resulting N-hydroxyphenacetin can be sulfated or glucuronidated. Whereas phenacetin N-0 sulfate immediately rearranges to form a reactive metabolite which may covalently bind to protein, phenacetin N-0 glucuronide slowly rearranges to form reactive metabolites. Incubation of the purified phenacetin N-0 glucuronide under a variety of conditions suggests that N-acetyl-p-benzoquinone imine is a reactive metabolite. This metabolite covalently binds to protein, reacts with glutathione to form an acetaminophen-glutathione conjugate, is reduced by ascorbate to acetaminophen or is partially hydrolyzed to acetamide. (2) Phenacetin can be 0-deethylated to acetaminophen, and acetaminophen can be converted directly to a reactive metabolite which may be also N-acetyl-p-benzoquinone imine. (3) Phenacetin can be sequentially Nhydroxylated and 0-deethylated to N-hydroxyacetaminophen which spontaneously dehydrates to Nacetyl-p-benzoquinone imine. (4) Phenacetin can be 3, 4-epoxidated to form an alkylating and an arylating metabolite. In the presence of glutathione, a S-ethylglutathione conjugate and an acetaminophen-glutathione conjugate are formed. In the absence of glutathione, the alkylating metabolite may bind to protein and the arylating metabolite is completely hydrolyzed to acetamide and another arylating metabolite which may bind to protein. The structures of the alkylating and arylating metabolites are unknown.
Introduction
Phenacetin p-ethoxyacetanilide) and acetaminophen (paracetamol, p-hydroxyacetanilide) are two of the more popular analgesic antipyretics. Acetaminophen was originally introduced in 1893, whereas phenacetin was introduced as an analgesic in 1897 (1) . Phenacetin has been a commonly used drug for many years; however, acetaminophen has become a widely used drug only in the last couple of decades 02.
While there has been a dramatic increase in acetaminophen consumption in recent years, there has been a sharp decrease in worldwide use of phenacetin. This is primarily attributable to kidney toxicities (analgesic nephropathy) and possible tumors associated with the abuse of phenacetin (3, 4) . Abuse of this drug has been defined as the consumption of at least one gram per day for at least three years (3, *National Center for Toxicological Research, Jefferson, AR 72079. 4 ). Analgesic nephropathy is characterized by interstitial nephritis and progressive reduction in renal size, secondary to repeated episodes of papillary necrosis (3, 4) . A high incidence of tumors of the urinary tract has also been correlated with abuse of this drug (5, 6 ).
An animal model for phenacetin-induced nephrotoxicity has not been developed; however, in rats (7) and hamsters (8) acute doses have been shown to produce a centrilobular hepatic necrosis. Chronic administration of phenacetin to rats has been recently reported to produce tumors of the urinary tract (9) .
The mechanism of these toxicities is unclear. Acetaminophen, which is the primary phenacetin metabolite, has not been shown to be carcinogenic, but in acute doses it produces a centrilobular hepatic necrosis in man and experimental animal (7, 10) .
The toxicity is mediated by a reactive metabolite which covalently binds to protein and is formed by the cytochrome P-450 mixed function oxidase system (11) (12) (13) (14) (Fig. 1) . Studies an important step in conversion of acetaminophen to the reactive metabolites (15) (16) (17) . For example, it was shown that the enzyme that N-hydroxylates pchloroacetanilide also may convert acetaminophen to a reactive metabolite. Since Calder et al. (18) showed that N-acetyl-p-benzoquinone imine was electrophilic, it was postulated that acetaminophen was N-hydroxylated and then immediately dehydrated to produce the reactive metabolite N-acetylp-benzoquinone imine (19) .
In this work we report mechanisms of formation of reactive metabolites of phenacetin which may be important in its toxicities, and in particular, the mechanism of phenacetin-induced hepatic necrosis in hamsters. Previous work on this hepatic toxicity had suggested that this necrosis may be mediated by a reactive metabolite which binds to protein (8) .
Materials and Methods
Chemicals N-Hydroxyphenacetin was synthesized by zinc reduction of p-nitrophenetole followed by acetylation with acetyl chloride (17 
Assays
Metabolites were isolated, purified and quantified by either high pressure liquid chromatography or thin-layer chromatography. Microsomal incubation mixtures were performed by using hamster liver microsomes. Sulfation assays were conducted with 100,000g rat liver supernatant which had been chromatographed on Sephadex G-25 to remove glutathione (21) . Glucuronidation assays were performed by using Triton X-100-treated rat liver microsomes (21) .
Results and Discussion

N-Hydroxylation of Phenacetin
Previous work suggested that phenacetin-induced hepatotoxicity in hamsters was mediated by a reactive metabolite which covalently bound to protein (8) . Since N-oxidation of acetaminophen was postulated to be an important step in acetaminophen-induced hepatotoxicity (11) (12) (13) (14) (15) 19) , the possibility was examined that phenacetin was Nhydroxylated to form a reactive metabolite. NHydroxyphenacetin was synthesized, and a chromatographic assay was developed to separate N-hydroxyphenacetin from other known phenacetin metabolites (17) . A metabolite with the chromatographic characteristics of N-hydroxyphenacetin was isolated from an incubation mixture of phenacetin, hamster liver microsomes, and NADPH. Mass spectral analysis indicated that the metabolite had a molecular ion and a fragmentation pattern identical to that of synthetic N-hydroxyphenacetin (17) . Com (23) , the role of sulfation or glucuronidation in the formation of a reactive metabolite was investigated. N-Hydroxyphenacetin was readily sulfated and glucuronidated in in vitro incubation mixtures (21) . Furthermore (27) . phen analogs p-chloroacetanilide (15, 16) and phenacetin (17) showed that these analogs were N-hydrox- (29) . Inasmuch as the data indicated that N-acetyl-p-benzoquinone imine was the reactive metabolite, it was postulated that acetaminophen was initially N-oxygenated at the active site of cytochrome P450 and that this species broke down, as shown in Figure 8 , to yield N-acetyl-pbenzoquinone imine instead of N-hydroxyacetaminophen (31) .
Conversion of Phenacetin to Reactive Metabolites by 3,4-Epoxidation
Incubation of [ring-3H]phenacetin with hamster liver microsomes and NADPH led to covalent binding to the microsomal protein (22) . Since inclusion of an excess of unlabeled acetaminophen in the incubation mixture did not decrease the amount of covalent binding, the binding is apparently not mediated by an initial deethylation to acetaminophen followed by metabolism of acetaminophen. Inclusion of glutathione in the microsomal incubation mixture blocked covalent binding to protein and a glutathione conjugate was formed. Surprisingly, when the conjugate was analyzed, it was an acetaminophen-glutathione conjugate. Since Daly (32) had presented evidence that other acetanilides, such as p-chloroacetanilide, may be metabolized by 3,4-epoxidation, the possibility was investigated that phenacetin may be analogously 3,4-epoxidated (22) . If phenacetin 3,4-epoxide were formed, it may rearrange, producing N-acetyl-pbenzoquinone imine. The importance of this mechanism was investigated by incubating phenacetin with microsomes, NADPH and glutathione in the presence of a molecular oxygen-18 atmosphere. If 3,4-epoxidation were the mechanism of activation of phenacetin, 180 may be expected to be quantitatively incorporated into the phenolic oxygen of the acetaminophen-glutathione conjugate. Mass spectral analysis of the acetaminophen- glutathione conjugate from this microsomal incubation mixture ( aThe "0 was substituted in the 4 position of both acetaminophen and phenacetin. Incubations were run in an air atmosphere, and the 180 content of the metabolites was determined by mass spectrometry (20) . of molecular oxygen into the metabolite. These findings suggest that phenacetin is converted to a reactive metabolite by an initial 3,4-epoxidation and that then an intermediate is formed in which the oxygen derived from molecular oxygen and the oxygen from phenacetin are equivalent (20) .
Further insight into the mechanism of formation of phenacetin reactive metabolites formed by 3,4-epoxidation was obtained by studying the microsomal metabolism of [ethyl-"4C]phenacetin, [acetyl-"4C]phenacetin and [ring-14C]phenacetin. Surprisingly, when [ethyl-14C]phenacetin was incubated with microsomes and NADPH, covalent binding of the radiolabel to microsomal protein was observed (Table 4) .
When glutathione was included in the incubation mixture, protein covalent binding was inhibited and a S-ethyl glutathione conjugate was formed. Deuterium isotope experiments using [ethyl-d5]phenacetin revealed that none of the protons was lost in the formation of the S-[ethyl-d5] glutathione conjugate.
The structure of the alkylating metabolite is unknown; however, its covalent binding to protein can be inhibited by ascorbate (Fig. 9) . Presumably, the reactive metabolite is not the iminoquinone hemiketal of phenacetin (33) (27) . Acetamide was a significant metabolite with [acetyl-"C]phenacetin but a minor metabolite of ['4C]acetaminophen (Table 4) . These findings indicate that even though the same acetaminophen-glutathione conjugate is formed from incubations of phenacetin and acetaminophen and ascorbate inhibits covalent binding with both substrates (Fig. 9) , the reactive intermediates are different. Since acetamide is known to be formed from quinone imines, presumably both the acetylated reactive intermediates are quinone imine derivatives. The deacetylated reactive metabolite, however, may be p-benzoquinone. This species is an electrophile and has been previously reported to conjugate with cysteine.
Mechanism of Conversion of Phenacetin to Reactive Metabolites In Vivo
The above data suggest that phenacetin may be metabolized to reactive metabolites by at least four different pathways: (1) N-hydroxylation followed by sulfation or glucuronidation (17, 21, 23) ; (2) deethylation to acetaminophen followed by oxidation of acetaminophen (2 12, 13, 30); (3) N-hydroxylation followed by O-deethylation (17, (27) (28) (29) ; and (4) 3,4-epoxidation (20, 22, 32) , (Fig. 10) . Each of these mechanisms yields an arylating metabolite which reacts with glutathione to produce an acetaminophen-glutathione conjugate. In vivo, this conjugate would be further metabolized and excreted in the urine as an acetaminophen-N-acetylcysteine conjugate (acetaminophen mercapturic acid) (2) . The (20) . Data on the metabolism of ethyl-labeled phenacetin £2) suggests that 3,4-epoxidation may be a primary contributor to the 10°h loss of 18O in the acetaminophen mercapturate.
When ethyl-labeled phenacetin was administered to hamsters, the S-ethyl-N-acetylcysteine and S-ethylcysteine conjugates were excreted and accounted for approximately 4% of the total dose 03). This 4% correlates quite closely with the 3% figure which was calculated above on assuming the 10% loss occurred solely by 3,4-epoxidation.
In conclusion, a number of pathways have been described whereby phenacetin can be converted to reactive metabolites. In hamsters, the primary mechanism of activation of phenacetin to reactive metabolites appears to be O-deethylation to acet-78 L aminophen followed by activation of acetaminophen and/or by N-hydroxylation of phenacetin followed by O-deethylation to N-hydroxyacetaminophen which spontaneously dehydrates. Since both acetaminophen and N-hydroxyacetaminophen produce hepatic necrosis, the hepatic toxicity observed with large doses of phenacetin in hamsters may be mediated by either mechanism or by a combination of the two.
